The urinary and reproductive tract can be affected by a number of diseases, such as lower urinary tract symptoms (LUTS), erectile dysfunction (ED) or premature ejaculation (PE) and disorders of multifactorial aetiology (resulting from the interaction of many factors). These conditions, which are common complaints in adult men, are often bothersome, negatively affect quality of life and are associated with a substantial economic burden for patients and health care systems. As the prevalence of LUTS and ED increases with age, e.g. approximately 40% of males have suffered some form of ED by the time reaching their forties, and this number is predicted to grow by approximately 10% per decade, it is expected that the burden of LUTS and ED will increase due to future demographic changes. This is what drives us at BERLIN-CHEMIE Menarini supplying medication for people with urinary and reproductive tract diseases such as LUTS due to Benign prostatic hyperplasia (BPH), erectile dysfunction (ED) and premature ejaculation (PE).